DR. MEERA WALIA JOINS VEHERE BOARD TO ACCELERATE INNOVATION AND INDUSTRY LEADERSHIP
Tuesday, March 4, 2025
SAN FRANCISCO, Feb. 24, 2025 /PRNewswire/ -- Vehere, a new-age cybersecurity software company, recently announced the induction of Dr. Meera Walia as an Independent Director to its Board. Dr. Walia brings over 40 years of extensive medical expertise, specializing in General Medicine and Ophthalmology, with a distinguished career spanning India, the USA, the UK, and the Middle East.
https://mma.prnewswire.com/media/2268795/4387329/Vehere__Logo.jpg
Dr. Walia was also involved in Life Insurance and Reinsurance, both front-end and offshoring, and in the design and development of clinical trial protocols in all phases of ethical conduct and monitoring of multi-center trials. Prior to joining Vehere, Dr. Walia was leading the Research and Analytics operations for a prominent multinational pharmaceuticals company at WNS. She has also been associated with renowned organizations like Aviva India and Genpact and was a commissioned officer in the Indian Army and the Royal Army of Oman in primary and secondary care.
Expressing her enthusiasm, Dr. Walia commented, "This is an exciting moment for me to become a part of Vehere. The exceptional technology the company has developed to serve both national security and enterprise security is indeed commendable. The passionate and competent team at Vehere, with their deep research skills and expertise, has made a real impact within defense and intelligence communities, as well as leading businesses, including financial institutions and telecom companies. I'm truly glad to be a part of an organization that's not just aiming for new heights in the global cybersecurity domain but conquering them."
"Dr. Walia's vast wealth of experience and mentorship will be instrumental in driving Vehere towards unprecedented success. We are thrilled to welcome her to the Board as Vehere continues its journey to becoming the world's leading cybersecurity company," said Vehere's Co-founders and Board members Naveen Jaiswal and Praveen Jaiswal.
Dr. Meera Walia is a graduate from Armed Forces Medical College, Pune, with a post-graduate degree in Ophthalmology, and a dual Masters in Hospital Administration.
About Vehere:
Vehere is a new-age cybersecurity software company specializing in AI Cyber Network Intelligence. For more than a decade, Vehere has been supporting counter-terrorism analysts in Defense and Intelligence communities. Vehere is now trusted by cyber-analysts in Fortune 500 companies, including Telecom, Financial Institutions, and Smart Cities to protect their critical infrastructure against real-time cyberattacks.
Vehere. HUNT BEFORE BREACH(TM)
Media Contact:
Arpan Majumder
arpan.majumder@vehere.com
Logo: https://mma.prnewswire.com/media/2268795/4387329/Vehere__Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dr-meera-walia-joins-vehere-board-to-accelerate-innovation-and-industry-leadership-302383105.html
SOURCE Vehere
|
|
|
|
|
 |
ASPG, Inc. Announces Release of MegaCryption-PC Administrator, A New Cryptography Administration Tool for Windows Administrators | Mar 28, 2025
|
|
Pentera Recognized as a Representative Vendor in the 2025 Gartner® Market Guide for Adversarial Exposure Validation (AEV) | Mar 28, 2025
|
|
Capitalizing on Growth: Why Financial Services Firms Need a Unified AI Strategy | Mar 28, 2025
|
|
WEBPRO Introduces Rare Domain Names for Sale Ahead of Auction | Mar 28, 2025
|
|
Netcraft Combines Forces with GASA and the GSE in the Fight Against Cybercrime | Mar 28, 2025
|
|
Birlasoft recognized by ISG for Innovative Digital Solutions | Mar 28, 2025
|
|
Crescendo Expands its Platform for CX with Agentic AI | Mar 28, 2025
|
|
Apollo TV Warns Customers About Fake Clone Sites and Unauthorized Sellers in 2025 | Mar 28, 2025
|
|
KNB Communications Launches KNB PRISM(TM) Index to Measure the Value of Healthcare Earned Media | Mar 28, 2025
|
|
TraceGains Launches First Purpose Built AI-Powered 'Certificate of Analysis' Solution to Eliminate Manual Processes and Improve Ingredient Safety and Compliance | Mar 28, 2025
|
|
|
